Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Merck KGaA, Darmstadt, Germany to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on 22nd March 2018

Merck
Posted on: 23 Mar 18

DARMSTADT, Germany, March 20, 2018 /PRNewswire/ -- Merck KGaA, Darmstadt, Germany (XETRA: MRK, OTC Pink: MKKGY), a leading science and technology company, today announced that it will present at the dbVIC - Deutsche Bank American Depositary Receipt (ADR) Virtual Investor Conference on 22nd March 2018. This virtual investor conference is aimed exclusively at introducing global companies with ADR programs to investors.

DATE:

March 22nd, 2018

TIME:   

11.30am ET

LINK:  

https://tinyurl.com/dbvic03prepr

This will be a live, interactive online event where investors are invited to ask international companies their questions in real-time and to download a company's information in their "virtual trade booth" in the Exhibits section. If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.

Participation is free of charge.

It is recommended that investors pre-register to save time and receive event updates.

Recent Company Highlights

Merck Achieves Targets for 2017 – Dividend to Increase

Merck Announced Positive Phase IIB Results for Evobrutinib in Relapsing Multiple Sclerosis

Mavenclad (Cladribine Tablets) Receives First Approval in Latin America, following approval in the EU, Canada, Australia and Israel

Merck Receives Patents for CRISPR Technology in U.S., Brazil, China, India, Japan, South Korea and Israel

About Merck KGaA, Darmstadt, Germany

Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2017, Merck KGaA, Darmstadt, Germany, generated sales of € 15.3 billion in 66 countries.

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 23/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.